The American Thoracic Society says the FDA approved the asthma treatment with lack of consideration for patient safety and for a public policy process.
The American Thoracic Society says the FDA approved the asthma treatment with lack of consideration for patient safety and for a public policy process.
The US Food and Drug Administration has approved adalimumab-adaz (Hyrimoz), a biosimilar to adalimumab (Humira), for the treatment of rheumatoid arthritis, juvenile...
